EUVIMEDEUVIMED entdecken
Crossref

Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications

Joseph K Byorth iD, Silvia M Soule iD, Brayden J Seliger, Richard D Bavier, Sarah M Drejet, Richard B Cannon, Marcus M Monroe, Luke O Buchmann, Jason P Hunt, Hilary C McCrary

Head & Neck · 2026-12 · 48 (12) · 3393-3398

DOI: 10.1002/hed.70376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 25.06.2026. Verfasst von Joseph K Byorth und 9 weiteren Autor:innen. Beteiligte Einrichtung: Creighton University School of Medicine, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Ketorolac, Head and Neck Neoplasms, Free Tissue Flaps, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The primary goal of the study is to assess bleeding complications and evaluate ketorolac for its safety in cancer patients undergoing head and neck free‐flap surgery.

Methods

Two cohorts of head and neck cancer patients undergoing free‐flap surgery were identified using ICD‐10 and CPT codes. Cohort 1 received ketorolac within 5 days of surgery ( n = 2280); Cohort 2 did not receive ketorolac within 5 days of surgery ( n = 2280). Postoperative hemorrhage occurrence and secondary outcomes were assessed.

Results

Ketorolac was not associated with increased risk of postoperative hemorrhage (RR: 0.825, p = 0.016), flap revisions (RR: 0.767, p < 0.001), blood vessel repair (RR: 0.528, p < 0.001), AKI (RR: 0.664, p = 0.003), and G‐tube placement (RR: 0.884, p = 0.021).

Conclusions

In this retrospective cohort, postoperative ketorolac was not associated with increased complications within the 30‐day period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetorolacHead and Neck NeoplasmsFree Tissue FlapsAnti-Inflammatory Agents, Non-SteroidalPostoperative HemorrhageHumansFemaleMaleRetrospective StudiesMiddle AgedAgedPostoperative ComplicationsCohort StudiesPlastic Surgery Procedures

Stichwörter der Autor:innen

free tissue transferfree‐flap reconstructionketorolacpostoperative hemorrhagesafety outcomes

Substanzen

KetorolacAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Creighton University School of Medicine, Omaha, Nebraska, USA.
  • Department of Otolaryngology-Head and Neck Surgery, The University of Utah, Salt Lake City, Utah, USA.
  • University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.

ORCID-Profile: Joseph K Byorth, Silvia M Soule

Zitieren

APA

Byorth, J. K., Soule, S. M., Seliger, B. J., Bavier, R. D., Drejet, S. M., Cannon, R. B., Monroe, M. M., Buchmann, L. O., Hunt, J. P., & McCrary, H. C. (2026). Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications. Head & Neck, 48(12), 3393-3398. https://doi.org/10.1002/hed.70376

Vancouver

Byorth JK, Soule SM, Seliger BJ, Bavier RD, Drejet SM, Cannon RB, et al. Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications. Head & Neck. 2026;48(12):3393-3398. doi:10.1002/hed.70376

BibTeX
@article{Byorth2026,
  author = {Byorth, Joseph K and Soule, Silvia M and Seliger, Brayden J and Bavier, Richard D and Drejet, Sarah M and Cannon, Richard B and Monroe, Marcus M and Buchmann, Luke O and Hunt, Jason P and McCrary, Hilary C},
  title = {Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications},
  journal = {Head & Neck},
  year = {2026},
  volume = {48},
  number = {12},
  pages = {3393--3398},
  doi = {10.1002/hed.70376}
}
Kostenlos starten →